Amy Whittle, MD
Family Medicine · Omaha, NENPI 1659786796
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 31.8% of the total. 2025 is the largest year on record at $545, 2.7 times the $205 reported in 2022.
Across 90 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$496
- Novo Nordisk$226
- Johnson & Johnson$143
- Organon$87
- AstraZeneca$82
- Amgen$75
- plus $451 from 19 others
What the payments were for
- Food & beverage$1,560100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $496 |
| Novo Nordisk | 16 | $226 |
| Johnson & Johnson | 7 | $143 |
| Organon | 5 | $87 |
| AstraZeneca | 5 | $82 |
| Amgen | 5 | $75 |
| Mylan Specialty L.p. | 3 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $49 |
| Boehringer Ingelheim | 3 | $46 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $30 |
| Lilly USA, LLC | 2 | $27 |
| Sandoz | 1 | $25 |
| Abbott | 1 | $24 |
| Merck | 1 | $23 |
| Biogen | 1 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
| Philips North America LLC | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Grifols USA, LLC | 1 | $16 |
| GSK | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
| Actelion Pharmaceuticals US, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$1,560 in reported general payments places this provider in the 70th percentile of 981 family medicine providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 18 | $501 |
| Omeprazole | 23 | $335 |
| Atorvastatin Calcium | 36 | $298 |
| Levothyroxine Sodium | 28 | $250 |
| ClopidogrelClopidogrel Bisulfate | 12 | $215 |
| Pantoprazole Sodium | 13 | $179 |
| Metoprolol Succinate | 14 | $166 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $159 |
| Losartan Potassium | 16 | $155 |
| Simvastatin | 15 | $101 |
| Metformin Hcl | 13 | $81 |
| Lisinopril | 24 | $79 |
| Amlodipine Besylate | 17 | $59 |
| Sertraline Hcl | 12 | $40 |
| Prednisone | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Omaha
- Gerard StanleyOmaha$50K
- Yongge LiuOmaha$15K
- M DadaOmaha$14K
- Christopher ConnollyOmaha$12K
- Paul VanaOmaha$12K
- Stephen TetraultOmaha$11K
- James RamigOmaha$11K
- Jeffrey RappOmaha$10K
- Christine Carlson RahnOmaha$10K
- Joseph DumbaOmaha$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.